Defilade Capital Management, L.P.
CIK 2088557 · View on SEC EDGAR ↗
- Portfolio value
- $746.9M
- Positions
- 39
- As of
- June 30, 2026
#2,962 of 9,443 by 13F value · top 31.4%
Portfolio value QoQ: +4.9% 13F does not disclose cash
- Top 10 holdings weight
- 46.51%
- Top 25 holdings weight
- 83.08%
- Positions above 1%
- 37
- Effective number of positions
- 29.2
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 59.83% Est. buys $436,516,436 · sells $441,402,660
- New positions
- 20
- Increased
- 8
- Decreased
- 10
- Closed
- 12
On this page
- Performance vs S&P How this manager's 13F portfolio performed against the S&P 500.
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- Biggest new bets Brand-new positions opened in the latest quarter.
- Top moves The biggest position increases and decreases this quarter.
- Exited positions Positions the manager fully sold out of last quarter.
Performance vs S&P 500
Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.
Priceable coverage: 100.0% · Options excluded: 0.0%
Sector breakdown
Healthcare
96.6%
Other/Unmapped
3.4%
Full portfolio 39 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company Common Stock | $46,880,921 | 6.28% | 39,086 | $27,845,361 | Up ×1 | ||
| PFE Pfizer, Inc. Common Stock | $42,663,571 | 5.71% | 1,771,743 | $1,550,829 | Up ×1 | ||
| VEEV Veeva Systems Inc. Class A Common Stock | $42,008,746 | 5.62% | 236,709 | Up ×1 | |||
| BMRN BioMarin Pharmaceutical Inc. - Common Stock | $39,024,326 | 5.22% | 682,005 | Up ×1 | |||
| PTCT PTC Therapeutics, Inc. - Common Stock | $35,376,827 | 4.74% | 433,699 | $9,748,706 | Up ×1 | ||
| BAX Baxter International Inc. Common Stock | $31,113,982 | 4.17% | 1,459,380 | Up ×1 | |||
| INSM Insmed Incorporated - Common Stock | $30,049,568 | 4.02% | 281,838 | $-1,821,952 | Up ×2 | ||
| ZBH Zimmer Biomet Holdings, Inc. Common Stock | $27,327,204 | 3.66% | 317,426 | $-25,040,534 | Down ×1 | ||
| PODD Insulet Corporation - Common Stock | $26,937,897 | 3.61% | 176,932 | Up ×1 | |||
| TMO Thermo Fisher Scientific Inc Common Stock | $26,037,630 | 3.49% | 51,934 | Up ×1 | |||
| ABT Abbott Laboratories Common Stock | $25,931,496 | 3.47% | 285,778 | Up ×1 | |||
| Unknown issuer (CUSIP: K08588103) | $25,296,525 | 3.39% | 94,843 | Up ×1 | |||
| SOLV Solventum Corporation Common Stock | $24,414,426 | 3.27% | 316,454 | Up ×1 | |||
| MDT Medtronic plc. Ordinary Shares | $23,727,237 | 3.18% | 303,301 | Up ×1 | |||
| ELAN Elanco Animal Health Incorporated Common Stock | $21,265,009 | 2.85% | 864,080 | $-1,016,717 | Down ×1 | ||
| AGIO Agios Pharmaceuticals, Inc. - Common Stock | $20,293,529 | 2.72% | 546,848 | Up ×1 | |||
| NVST Envista Holdings Corporation Common Stock | $19,132,946 | 2.56% | 726,108 | Up ×1 | |||
| RVMD Revolution Medicines, Inc. - Common Stock | $15,511,841 | 2.08% | 82,827 | $-15,216,436 | Down ×2 | ||
| ICUI ICU Medical, Inc. - Common Stock | $15,495,620 | 2.07% | 105,700 | $-17,346,063 | Down ×2 | ||
| COGT Cogent Biosciences, Inc. - Common Stock | $15,226,167 | 2.04% | 393,441 | $1,654,978 | Up ×1 | ||
| LNTH Lantheus Holdings, Inc. - Common Stock | $14,717,522 | 1.97% | 132,662 | $-4,199,544 | Down ×1 | ||
| OCUL Ocular Therapeutix, Inc. - Common Stock | $14,634,609 | 1.96% | 1,490,286 | $2,034,256 | Up ×2 | ||
| ELDN Eledon Pharmaceuticals, Inc. - Common Stock | $13,889,832 | 1.86% | 3,525,338 | $2,912,321 | Down ×1 | ||
| TYRA Tyra Biosciences, Inc. - Common Stock | $12,037,228 | 1.61% | 376,870 | Up ×1 | |||
| OLMA Olema Pharmaceuticals, Inc. - Common Stock | $11,568,723 | 1.55% | 924,758 | $-10,863,909 | Down ×1 | ||
| ORIC Oric Pharmaceuticals, Inc. - Common Stock | $11,346,483 | 1.52% | 1,047,690 | $666,585 | Up ×1 | ||
| LRMR Larimar Therapeutics, Inc. - Common Stock | $11,193,912 | 1.50% | 3,670,135 | Up ×1 | |||
| GMED Globus Medical, Inc. Class A Common Stock | $11,032,719 | 1.48% | 139,637 | $-19,498,077 | Down ×1 | ||
| ENOV Enovis Corporation Common Stock | $11,011,262 | 1.47% | 531,945 | Up ×1 | |||
| EVMN Evommune, Inc. Common Stock | $10,540,897 | 1.41% | 793,145 | $-5,059,864 | Up ×2 | ||
| TFX Teleflex Incorporated Common Stock | $10,155,758 | 1.36% | 80,118 | ||||
| DNLI Denali Therapeutics Inc. - Common Stock | $10,078,794 | 1.35% | 391,866 | $-16,032,611 | Down ×1 | ||
| GKOS Glaukos Corporation Common Stock | $9,296,695 | 1.24% | 66,519 | ||||
| STAA STAAR Surgical Company - Common Stock | $9,241,795 | 1.24% | 322,126 | Up ×1 | |||
| PACS PACS Group, Inc. Common Stock | $9,196,382 | 1.23% | 215,675 | $-10,209,880 | Down ×2 | ||
| CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | $8,959,845 | 1.20% | 239,440 | Up ×1 | |||
| LIVN LivaNova PLC - Ordinary Shares | $8,829,282 | 1.18% | 107,373 | ||||
| BDTX Black Diamond Therapeutics, Inc. - Common Stock | $3,098,748 | 0.41% | 1,674,999 | Up ×1 | |||
| MREO Mereo BioPharma Group plc - American Depositary Shares | $2,401,417 | 0.32% | 7,558,756 | $-92,972 | |||
| No matches | |||||||
Biggest new bets
New positions opened this quarter, largest first.
| Security | Value | Shares | % of portfolio |
|---|---|---|---|
| VEEV | $42,008,746 | 236,709 | 5.62% |
| BMRN | $39,024,326 | 682,005 | 5.22% |
| BAX | $31,113,982 | 1,459,380 | 4.17% |
| PODD | $26,937,897 | 176,932 | 3.61% |
| TMO | $26,037,630 | 51,934 | 3.49% |
| ABT | $25,931,496 | 285,778 | 3.47% |
| Unknown issuer (CUSIP: K08588103) | $25,296,525 | 94,843 | 3.39% |
| SOLV | $24,414,426 | 316,454 | 3.27% |
| MDT | $23,727,237 | 303,301 | 3.18% |
| AGIO | $20,293,529 | 546,848 | 2.72% |
| NVST | $19,132,946 | 726,108 | 2.56% |
| TYRA | $12,037,228 | 376,870 | 1.61% |
| LRMR | $11,193,912 | 3,670,135 | 1.50% |
| ENOV | $11,011,262 | 531,945 | 1.47% |
| TFX | $10,155,758 | 80,118 | 1.36% |
Top movers (QoQ)
| Security | Action | Shares Δ | Value Δ |
|---|---|---|---|
| LLY | Bought more | +18K | +$27.8M |
| ZBH | Trimmed | -262K | -$25.0M |
| GMED | Trimmed | -215K | -$19.5M |
| ICUI | Trimmed | -149K | -$17.3M |
| DNLI | Trimmed | -968K | -$16.0M |
| RVMD | Trimmed | -233K | -$15.2M |
| OLMA | Trimmed | -580K | -$10.9M |
| PACS | Trimmed | -389K | -$10.2M |
| PTCT | Bought more | +58K | +$9.7M |
| EVMN | Bought more | +115K | -$5.1M |
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| ABBV | March 31, 2026 | 227,669 | $52,020,090 | 21.3% |
| NVS | March 31, 2026 | 362,816 | $50,021,442 | 2.8% |
| HSIC | June 30, 2026 | 624,037 | $45,991,527 | 5.8% |
| BDX | June 30, 2026 | 279,210 | $43,900,188 | 24.8% |
| STE | March 31, 2026 | 135,307 | $34,303,031 | 6.9% |
| DXCM | June 30, 2026 | 538,762 | $33,834,254 | 32.8% |
| ISRG | June 30, 2026 | 67,681 | $31,200,264 | -6.1% |
| NBIX | June 30, 2026 | 209,932 | $27,656,442 | -8.6% |
| XNCR | March 31, 2026 | 1,414,755 | $21,659,899 | 130.8% |
| ITGR | June 30, 2026 | 213,027 | $18,746,376 | 34.2% |
| BIIB | June 30, 2026 | 96,289 | $17,652,662 | -0.2% |
| ATRC | March 31, 2026 | 397,636 | $15,730,480 | 65.8% |
| LIVN | March 31, 2026 | 241,413 | $14,854,142 | 23.1% |
| TNDM | June 30, 2026 | 761,905 | $14,605,719 | 47.4% |
| NUVL | June 30, 2026 | 129,950 | $13,313,378 | No longer tracked |
| ATEC | March 31, 2026 | 626,754 | $13,186,904 | -15.6% |
| ASND | June 30, 2026 | 51,895 | $11,869,943 | -3.3% |
| ALGN | June 30, 2026 | 67,332 | $11,542,725 | -5.8% |
| GKOS | March 31, 2026 | 91,703 | $10,354,186 | 71.7% |
| RXST | March 31, 2026 | 913,090 | $9,514,398 | -1.6% |
| TFX | March 31, 2026 | 42,850 | $5,229,414 | 12.8% |
| CNMD | March 31, 2026 | 104,129 | $4,227,637 | 44.4% |
| BHVN | June 30, 2026 | 315,944 | $2,672,886 | -4.2% |